CORK, Ireland — June 15, 2009 — Radisens Diagnostics was recently announced as thehe winner of the Genesis Emerging Business of the Year Award for 2008/09. Radisens is a medical diagnostics startup developing affordable optical detection platforms for use in diagnostic instruments at point of care.  Delivering significant cost and size reductions  compared with incumbent solutions, these platforms (measuring the size of a matchbox) will drive the decentralisation of diagnostics from the central reference laboratory into hospital and physician laboratories.  Radisens’ patent pending approach results in an affordable and robust platform that can be configured across multiple applications including standard blood testing, early cancer detection and infectious diseases diagnosis within 5 minutes of taking a blood/urine sample from the patient.

» Full story

About Radisens Diagnostics

Radisens develops portable diagnostic platforms for point-of-care, resulting in rapid and reliable laboratory-grade blood testing across multiple assays. Radisens is miniaturizing gold-standard clinical laboratory diagnostic instrumentation and developing a consummable suite covering immunoassay, haematology and molecular diagnostic tests. No solution on the market offers a multiplexed, quantitative platform for blood testing across such a wide range of applications in a single portable, battery-operated instrument. This patent pending disruptive technology will drive a step change towards ubiquitous rapid handheld analysis in GP clinics, outpatient and emergency room settings.